PHI, Inc.
PHII
PHII was delisted on the 25th of March, 2019.
11 hedge funds and large institutions have $5.07M invested in PHI, Inc. in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
15% less funds holding
Funds holding: 13 → 11 (-2)
15% less capital invested
Capital invested by funds: $6M → $5.07M (-$927K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$75.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.96K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RR
Robotti Robert
|
-$205K |
| 2 |
Franklin Resources
San Mateo,
California
|
-$146K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.23K |
| 4 |
Morgan Stanley
New York
|
-$76 |
PHII Hedge Fund Activity: Q2 2016 in Review
11 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PHI, Inc. (PHII) for Q2 2016, worth a combined $5.07M — down 15% from $6M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHII and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Citigroup, adding an estimated $75.7K. The largest seller was Robotti Robert, exiting entirely with an estimated $205K sold.
- 11 institutional investors held PHI, Inc. (PHII) as of Q2 2016, down from 13 in Q1 2016.
- Funds reported $5.07M of PHI, Inc. stock for Q2 2016, down 15% quarter-over-quarter.
- 0 funds opened new PHI, Inc. positions in Q2 2016 and 2 closed out, a net change of -2 holders.
- The largest PHI, Inc. buyer in Q2 2016 was Citigroup, an estimated $75.7K added.
- The largest PHI, Inc. seller in Q2 2016 was Robotti Robert, an estimated $205K sold.
Based on aggregated 13F filings for Q2 2016.